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Pathological lymphatic diseases mostly affect ves-
sels in specific tissues, yet little is known about
organ-specific regulation of the lymphatic vascula-
ture. Here, we show that the vascular endothelial
growth factor receptor 3 (VEGFR-3)/p110a PI3-
kinase signaling pathway is selectively required for
the formation of mesenteric lymphatic vasculature.
Using genetic lineage tracing, we demonstrate that
part of the mesenteric lymphatic vasculature
develops from cKit lineage cells of hemogenic endo-
thelial origin through a process we define as lymph-
vasculogenesis. This is contrary to the current
dogma that all mammalian lymphatic vessels form
by sprouting from veins. Our results reveal
vascular-bed-specific differences in the origin and
mechanisms of vessel formation, whichmay critically
underlie organ-specific manifestation of lymphatic
dysfunction in disease. The progenitor cells identi-
fied in this study may be exploited to restore
lymphatic function following cancer surgery, lym-
phedema, or tissue trauma.
INTRODUCTION
The circulatory system is composed of hierarchical networks of
blood and lymphatic vessels with specific features serving their
specialized functions. Structural and functional differences1708 Cell Reports 10, 1708–1721, March 17, 2015 ª2015 The Authoramong arteries, capillaries, veins, and lymphatic vessels are re-
flected by unique transcriptional signatures within endothelial
cells lining these vessels (Aird, 2007a, b). In addition, vascular
beds of different organs show remarkable specialization that al-
lows them to fulfill the functional needs of each organ. For
example, capillary beds of the kidney and the brain show orga-
notypic features that reflect their opposite roles in controlling
passage of solutes between the tissue and the blood. Endothelial
cells of the kidney glomeruli have fenestrae for the filtration of
blood, while those of the blood-brain barrier display specialized
tight junctions and a low rate of vesicular transcytosis, thus form-
ing a barrier that seals the central nervous system (Aird, 2007b;
Engelhardt and Liebner, 2014). Gene expression profiling of
microvascular endothelial cells from different organs revealed
unique transcriptional signatures for transcription factors and
adhesion molecules (Nolan et al., 2013). In addition, tissue-spe-
cific endothelial cells produce a unique repertoire of angiocrine
growth factors and chemokines, which indicates an important
role for the vasculature in organ development, homeostasis,
and regeneration (Butler et al., 2010a, 2010b; Ding et al., 2010;
Kusumbe et al., 2014; Nolan et al., 2013).
Embryonic blood vessels form via two fundamentally different
mechanisms, de novo formation of vessels from endothelial pro-
genitors (vasculogenesis) and sprouting of vessels from pre-ex-
isting ones (angiogenesis). In contrast, mammalian lymphatic
vasculature is thought to form exclusively through an angiogenic
process involving endothelial cell sprouting from the veins (lym-
phangiogenesis) (Srinivasan et al., 2007). Upon exit from the
vein, the differentiated lymphatic endothelial cells (LECs) form
the first primitive lymphatic structures called lymph sacs, from
which lymphatic vessels of peripheral organs are formed vias
further sprouting. Although much has been learned about the
general mechanisms of blood and lymphatic vessel formation,
organ-specific vascular development and specialization remain
poorly understood. Extracellular signals provided by the specific
tissue microenvironment are likely to play a key role in this pro-
cess, but cell-intrinsic genetic mechanisms also are involved.
For example, canonical Wnt7a/Wnt7b signaling was shown to
control organ-specific formation of the CNS vasculature, while
Mfsd2a specifically regulates the formation of the blood-brain
barrier (Armulik et al., 2010; Ben-Zvi et al., 2014; Stenman
et al., 2008).
Dysfunction of lymphatic vasculature recently has been linked
to a number of human pathologies, including inflammation,
obesity, and cardiovascular disease (Alitalo, 2011). A prominent
clinical consequence of the failure of the lymphatic system,
caused by a genetic defect or damage following surgery or
trauma, is tissue swelling or lymphedema. Notably, several he-
reditary lymphedemas are characterized by defects that affect
specific tissues or organs. For example, in Milroy disease and
lymphedema-distichiasis syndrome, which are caused by muta-
tions in genes encoding VEGFR-3 and FOXC2, respectively, lym-
phedema is restricted to the lower limbs (Connell et al., 2013). In
other syndromes, it also can occur in hands or genitalia, or
manifest as a generalized lymphatic dysplasia with a degree of
systemic involvement, such as intestinal or pulmonary lymphan-
giectasia (Connell et al., 2013). Molecular mechanisms underly-
ing organ-specific manifestation of lymphatic dysfunction are
not characterized, yet this knowledge is instrumental in
designing therapeutic strategies for lymphedema and other
lymphatic disorders, which are currently lacking.
Here we identify a hitherto unrecognized mechanism by which
lymphatic vascular morphogenesis is regulated in an organ-spe-
cific manner. We show that VEGFR-3/PI3K signaling is selec-
tively required for the formation of mesenteric lymphatic vessels.
Using genetic lineage tracing, we further demonstrate that, con-
trary to current belief that all mammalian lymphatic vessels form
by sprouting from veins, part of the mesenteric lymphatic vascu-
lature forms from non-venous-derived progenitors of hemogenic
endothelial origin.
RESULTS
VEGFR-3/PI3K Signaling Is Selectively Required for
Mesenteric Lymphatic Vessel Development
To understand organ-specific mechanisms of lymphangiogene-
sis, we investigated the requirement of the key lymphangiogenic
growth factor receptor, VEGFR-3, in the development of different
lymphatic vascular beds. Since homozygous deletion of Vegfr3
is expected to lead to loss or severe hypoplasia of lymphatic
vessels in all organs, we instead analyzed hypomorphs with
partial and selective deficiency of VEGFR-3 signaling via the
PI3-kinase pathway. For this purpose, we generated mice car-
rying single functional copies of genes encoding VEGFR-3 and
the p110a catalytic subunit of PI3K, which is the key downstream
effector of VEGFR signaling in blood and lymphatic endothelia
(Graupera et al., 2008; Gupta et al., 2007; Vanhaesebroeck
et al., 2010). Mice carrying a heterozygous Vegfr3 null (Vegfr3lz/+)
or a heterozygous kinase-dead PIK3CA allele (denoted asCellp110aD933A/+) developed into adulthood and showed normal
lymphatic vasculature (Dumont et al., 1998; Graupera et al.,
2008; data not shown). In contrast, double-heterozygous
Vegfr3lz/+;p110aD933A/+ animals died perinatally and exhibited
vascular defects characterized by near absence of mesenteric
lymphatic vessels and leakage of chylous fluid (Figures S1A–
S1C). While in control mice each artery-vein pair extending
from the mesenteric root to the intestine is accompanied by a
lymphatic vessel (Figure S1C; data not shown), only a rare and
often truncated lymphatic vessel could be found in neonatal
Vegfr3lz/+;p110aD933A/+ mice at P0–P4 (Figures S1C, 1A, and
1B). The few lymphatic vessels that developed in the mutant
mesentery were dilated and exhibited abnormal expression of
LYVE-1, which was downregulated inmesenteric vessels of con-
trol neonatal mice (Figure S1C).
To exclude the possibility that the lymphatic phenotype was
due to growth retardation, we analyzed mice at embryonic
stages when Vegfr3lz/+;p110aD933A/+ animals were recovered
at normal Mendelian ratio with no detectable gross abnor-
malities (Figure S1A). Immunofluorescence analysis using the
established lymphatic markers Nrp2 and Prox1 showed that
the majority (8 of 10) of double-heterozygous embryos
completely lacked mesenteric and intestinal submucosal
lymphatic vessels at embryonic day (E)14–E17 (Figures 1A,
1B, and S1D). Mice that do not develop any mesenteric
lymphatic vessels are expected to die shortly after birth, as
they are unable to absorb dietary fats. In agreement, about
50% of the double-heterozygous mice died immediately after
birth (Figure S1A). Mutants with a complete loss of lymphatic
vessels were only observed at P0 (data not shown), while
from P1 onward, all surviving pups had at least one mesenteric
lymphatic vessel (Figure 1B; data not shown). Additionally, the
mesenteric lymph sac at the root of the mesentery was
reduced in size or absent in the Vegfr3lz/+;p110aD933A/+ em-
bryos (Figures 1A and 1C). Surprisingly, however, lymphatic
vessels in the diaphragm, which are thought to develop from
the same lymph sac as the mesenteric lymphatic vasculature,
as well as dermal lymphatic vessels formed in Vegfr3lz/+;
p110aD933A/+ mice (Figures 1A, 1D, and S1E). Blood vascula-
ture in the skin, mesentery, and intestine also was unaffected
in the double-heterozygous mice (Figures 1A, S1C, and S1D).
p110a specifically cooperated with VEGFR-3 and not VEGFR-
2, the other lymphatic endothelial VEGFR, since Vegfr2flox/-;
p110aD933A/+ mice developed into adulthood and showed
normal lymphatic vasculature (Figures S2A and S2B).
To further explore the selective requirement of VEGFR-3/PI3K
signaling for mesenteric lymphatic vessel development, we
genetically deleted p110a in all lymphatic vessels by crossing
p110aflox mice (Graupera et al., 2008) with Vegfr3-CreERT2 ani-
mals (I.M.-C. and S.O., unpublished data). To first validate
the previously unpublished Vegfr3-CreERT2 mice, we crossed
them to the R26-mTmG reporter mice that allow monitoring of
Cre activity by the expression of membrane-bound green fluo-
rescent protein (GFP) and concomitant inactivation of red fluo-
rescent protein Tomato expression (Muzumdar et al., 2007).
The 4-hydroxytamoxifen (4-OHT) administration to pregnant fe-
males led to efficient Cre-mediated recombination in dermal
(85.8% ± 2.0%, n = 4) and mesenteric (78.6% ± 7.0%, n = 4)Reports 10, 1708–1721, March 17, 2015 ª2015 The Authors 1709
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lymphatic vessels in Vegfr3-CreERT2;R26-mTmG embryos at
E15.5 (Figures 1E and S3A). On the contrary, Cre recombination
in blood endothelia was very low (8.0% ± 0.8% and 7.0% ±
0.5% in skin and mesentery, respectively, n = 4) (Figure 1E).
Similar recombination efficiency was observed at E17.5 (Fig-
ure S3B). In control mesentery, lymphatic vessels were visual-
ized by GFP fluorescence (Figure 1F). In contrast, deletion of
p110a in all lymphatic vessels in p110aflox/flox; Vegfr3-
CreERT2;R26-mTmG mice led to a reduced number of mesen-
teric lymphatic vessels, although the mesenteric lymph sac
formed normally (Figures 1F and 1G). Dermal lymphatic vessels
showed normal sprouting and branching in the mutant
compared to control embryos (Figures 1H and 1I). Dermal and
mesenteric blood vessels also appeared normal in the mutants
(Figure 1F; data not shown), as expected given the low level of
Cre-mediated p110a deletion in blood endothelia in the
Vegfr3-CreERT2 line (Figure 1E). Together, these results demon-
strate a selective requirement of VEGFR-3/PI3K signaling,
mediated via the p110a PI3K pathway, for the formation of
mesenteric lymphatic vasculature.
Venous-Derived LECs Form the Mesenteric Lymph Sac
Next we investigated whether the mesentery-specific VEGFR-3/
PI3K signaling requirement reflects a unique mechanism of
vessel formation in this tissue. Early lymphatic development in
the jugular region, where LECswere shown to differentiate within
cardinal and superficial veins, has been studied extensively (Ha¨-
gerling et al., 2013; Srinivasan et al., 2007; Yang et al., 2012).
Following their exit from the veins, LECs form the peripheral lon-
gitudinal lymphatic vessel (PLLV) and primordial thoracic duct
(pTD), commonly referred to as jugular lymph sac, from which
vessels sprout further to peripheral organs such as skin (Ha¨gerl-
ing et al., 2013; Srinivasan et al., 2007; Yang et al., 2012). In the
mesentery, LECs are thought to similarly differentiate within ma-
jor veins at the root of the mesentery and exit the veins to form a
single retroperitoneal (also called mesenteric) lymph sac, from
which vessels of the mesentery and the diaphragm are formed
(Sabin, 1902; van der Putte, 1975; Figure 2A). To capture this
process, we analyzed the mesenteric root between E12 andFigure 1. Organ-Specific Requirement of VEGFR-3/p110a PI3K Signali
(A) Whole-mount immunofluorescence of E14.5 wild-type and Vegfr3lz/+;p110aD
marker Endomucin (blue). Mutant embryos lack lymphatic vessels (LVs) specific
(B and C) Quantification of mesenteric LV (MLV) and lymph sac (MLS) phenotyp
(P0–P4) stages. All controls showed complete LV coverage. In (C), complete repr
(D) Quantification of dermal LV branching and sprouting in E15.5 wild-type and V
Data represent mean ± SEM.
(E) (Top) Schematic of the Vegfr3-CreERT2 transgene, R26-mTmG reporter con
mTom/mGFP, membrane-bound Tomato/GFP. The timing of pTD and PLLV fo
CreERT2;R26-mTmG embryos showing GFP expression, indicating Cre recombin
plots and gating scheme. (Right) Graphs of all results; the horizontal lines repres
(F and H) Whole-mount immunofluorescence of control (p110aflox/+ or p11
CreERT2;R26-mTmG) mesenteries (E17.5) and skin (E14.5) for indicated protein
shows efficient Cre-mediated recombination in LVs and lack of vessels in the mut
Note that Nrp2 is additionally expressed in the nerves and veins. Asterisk, MLS;
(G) Quantification of MLV and MLS phenotypes. For LS, complete represents th
(I) Quantification of dermal LV branching and sprouting in E17.5 control and p110a
Data represent mean ± SEM.
See also Figures S1–S3 and Table S1.
Scale bars, 100 mm (A and F; mesenteric vessels, LS, diaphragm), 200 mm (A an
CellE14 using high-resolution immunofluorescence confocal micro-
scopy. Using Prox1 and Endomucin as markers of LECs and
venous blood endothelial cells (BECs), respectively, we first de-
tected Prox1-positive LECs within the superior mesenteric vein
at E12.5 (Figure 2B). At E13 all Prox1-positive cells were found
outside the vein organized in cord-like structures and expressing
high levels of the established LEC marker Nrp2 (Figure 2B). At
E14, LECs formed an extensive lymphatic plexus adjacent to
the superior mesenteric vein (Figure 2B). These data are consis-
tent with the current model of lymphatic development, and they
suggest that the mesenteric lymph sac is of venous origin and
forms between E12 and E14.
The origin of themesenteric lymph sacwas analyzed further by
lineage tracing using an inducible endothelial-specific Pdgfb-
CreERT2 line (Claxton et al., 2008) in combination with the R26-
mTmG double reporter (Figure 2C). Upon 4-OHT administration,
Pdgfb-expressing endothelial cells and their descendants were
labeled with GFP. Genetic labeling of blood endothelium by
GFP at E11/E12, just prior to the onset of mesenteric lymphatic
development, led to significant labeling of the lymph sac (Fig-
ure 2C), thus confirming the contribution of venous-derived cells
to the mesenteric lymph sac.
Mesenteric Lymphatic Vessels Form via the Assembly
of Isolated Endothelial Cell Clusters
We next analyzed the formation of mesenteric lymphatic ves-
sels that run parallel to mesenteric veins (Figure 2A) and are
thought to develop by sprouting from the mesenteric lymph
sac. Surprisingly, we observed isolated clusters of endothelial
cells that were positive for the LEC markers Prox1 and Nrp2
and located along mesenteric veins in the absence of contin-
uous vessel sprouts from the lymph sac (Figure 3A). Clusters
appeared between E13 and E13.5, rapidly increased in size
and number, and coalesced to form lymphatic vessels by
E14.5 (Figure 3A). Different stages of cluster and vessel forma-
tion frequently were observed within the same mesentery along
different artery-vein pairs, suggesting that cluster formation and
coalescence occur during a brief window of time (Figures 3A
and S4A).ng for Mesenteric Lymphatic Vessel Development
933A/+ tissues for LEC markers Nrp2 (green) and Prox1 (red) and venous EC
ally in the mesentery.
es in Vegfr3lz/+;p110aD933A/+ mice at embryonic (E14–E17) and early postnatal
esents the size of LS in control littermates (n = 5 [E14–E17] and n = 5 [P0–P4]).
egfr3lz/+;p110aD933A/+ embryos, showing no differences between the groups.
struct, and 4-OHT administration (Cre induction, red arrowheads) schedule.
rmation is indicated. FACS analysis of endothelial cells from E15.5 Vegfr3-
ation, in LECs and to a lesser extent in BECs. (Bottom) Representative FACS
ent mean (n = 4).
0a+/+;Vegfr3-CreERT2;R26-mTmG) and p110a mutant (p110aflox/flox;Vegfr3-
s. 4-OHT (1.5 mg) was administered at E10.5, E11.5, E12.5, and E13.5. GFP
ant mesentery. A mosaic pattern of recombination is detected in blood vessels.
N, nerve (Nrp2+); V, vein (Endomucin+).
e size of LS in controls (n = 3).
flox/flox;Vegfr3-CreERT2 embryos, showing no differences between the groups.
d H; skin), and 1 mm (mesentery whole-mount).
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Figure 2. Venous-Derived LECs Form the
MLS
(A) Schematic illustration ofmesenteric vasculature.
Blue, vein; red, artery; green, LV. Boxed regions
indicate areas analyzed by immunofluorescence.
(B) Whole-mount immunofluorescence of the
developing LS at the root of the mesentery for
indicated proteins. Stages of development are
shown. At E14 only the LS is visualized. Asterisk,
superior mesenteric vein.
(C) Schematic of the inducible Pdgfb-CreERT2
transgene and R26-mTmG reporter construct used
for lineage tracing of venous endothelia. The timing
of MLS formation is indicated. 4-OHT (1 mg) was
administered at E11 and E12 (red arrowheads) and
the MLS was analyzed at E14 by immunofluores-
cence with antibodies against GFP (green) and
Nrp2 (blue). LS showing mosaic GFP labeling is
shown.
Scale bars, 100 mm.We reasoned that the isolated LEC clusters could be formed of
cells that detached from the lymph sac and migrated along the
mesenteric veins. Alternatively, they may have differentiated
locally from mesenteric veins. To address these possibilities,
we characterized the morphological and molecular features of
LEC clusters. Cell shape was first analyzed by labeling indi-
vidual LECs with membrane-bound GFP using the Vegfr3-
CreERT2;R26-mTmG mice and a suboptimal dose of 4-OHT.
Cells within mesenteric LEC clusters extended long membrane
protrusions, often in a non-polarized fashion (Figure 3B), and
showed rounded nuclear morphology (Figure 3C). This was in
contrast to the elongated nuclear morphology that is associated
with a migratory phenotype (Kim et al., 2014), and that we
observed in LECs upon cluster coalescence into vessels (Fig-
ure 3C). Venous-derived LECs forming the mesenteric lymph
sac (Figure 3C), as well as the PLLV and pTD (Ha¨gerling et al.,
2013), also showed a more elongated nuclear morphology (Fig-
ure 3C). Mesenteric LECs within clusters thus lack features
typical of polarized cells undergoing directional migration, which
argues against their rapid migration from the lymph sac.
Mesenteric LEC clusters expressed the (lymphatic) endothelial
markers Prox1, Nrp2, VEGFR-3, VEGFR-2, and Podoplanin (Fig-
ure 3D). They were proliferative as indicated by EdU incorpora-
tion (Figure 3D). Surprisingly, LEC clusters expressed very low
levels of LYVE-1, whichwas highly expressed in lymph sac endo-
thelium (Figure 3E). In addition, LEC clusters did not express BEC1712 Cell Reports 10, 1708–1721, March 17, 2015 ª2015 The AuthorsmarkersCD34andEndomucin, or hemato-
poietic markers Sca1, CD41, c-Kit, or
CD45 (Figures 3F and S4B). Lack of CD34
and Endomucin expression in mesenteric
LECs suggests that they do not arise by
local differentiation and budding from
veins, which has been reported to lead to
perdurance of BEC marker expression for
24 hr (Ha¨gerling et al., 2013).
We sought further evidence for non-
venous origin of mesenteric lymphaticvessels by analyzing mice carryingCldn5-GFP transgene that la-
bels all vessels, including mesenteric arteries, veins, and the
lymph sac, by strong GFP fluorescence (Figure 3G). If generated
in situ from the existing mesenteric vasculature, perdurance of
GFP is expected to lead to GFP labeling of LECs, regardless of
Cldn5 promoter activity. However, a major proportion of LECs
in E14 Cldn5-GFP mesenteries were GFP (Figures 3G and
3H). Isolated single Prox1+ LECs and clusters of two cells were
mostly GFP (Figure 3H). Larger clusters showed variability in
GFP expression with some cells expressing high levels of GFP,
equivalent to those detected in already formed vessels, while
otherswereGFP (Figure 3H). The progressive increase in the in-
tensity of GFP from single cells to larger clusters suggests induc-
tion of Cldn5 expression first upon cluster and vessel formation.
Importantly, the abundance of GFP LECs suggests that mesen-
teric lymphatic vessels are not derived from mesenteric blood
vessels or the venous-derived lymph sac.
Mesenteric Lymphatic Vessels Originate from
Non-venous Endothelium
To trace the cell of origin of mesenteric LECs, we employed tem-
poral lineage tracing using the endothelial-specific Pdgfb-
CreERT2 line in combination with the R26-mTmG reporter. We
found that when 4-OHT was administered at E8–E8.5, to target
blood endothelium prior to the initiation of lymphatic develop-
ment (Figure 4A), mesenteric arteries and veins showed poor
or no labeling, respectively. Surprisingly, however, traced GFP+
cells were present in themesenteric LEC clusters and, to a lesser
degree, in the lymph sac (Figures 4B and S5A). On the contrary,
4-OHT administration at E9 or later resulted in increased labeling
ofmesenteric blood vessels but decreased labeling of LECs (Fig-
ure S5A). Fluorescence-activated cell sorting (FACS) analysis
confirmed an overall increase in the labeling of blood endothelia,
as well as venous-derived LECs, in E9 compared to E8 4-OHT-
treated embryos (Figure S5B). Taken together, these results sug-
gest selective targeting of LEC progenitors in the mesentery
upon early induction of Pdgfb-CreERT2. Furthermore, efficiency
of LEC labeling upon Cre induction at E8–E8.5 varied among
different embryos, suggesting a narrow window of time during
which the cell of origin of mesenteric LECs can be targeted
and/or when LEC progenitors are generated (Figure S5A).
To identify the source of mesenteric LECs, we carried out
detailed characterization of Cre recombination pattern in
Pdgfb-CreERT2;R26-mTmG embryos that were treated with
4-OHT at E8–E8.5. Whole-mount immunofluorescence of E9.5
embryos showed only a few scattered GFP+ cells in the cardinal
and vitelline veins (Figures 4C and S6A). Quantitative FACS anal-
ysis of LYVE-1+ LECs, at time points when venous LEC progen-
itors exit cardinal veins (E10.25) and form the first lymphatic
structures pTD and PLLV (E11), showed low levels of recombina-
tion (Figure 4D). Immunofluorescence analysis confirmed that
venous-derived jugular lymph sacs (pTD and PLLV) were not tar-
geted (Figure S6B). Instead, we observed efficient labeling of
major arteries, including the dorsal aorta and vitelline artery (Fig-
ures 4C and S6A). Hematopoietic cells including macrophages
were also efficiently labeled (Figures 4B and S6C), suggesting
the targeting of blood-forming hemogenic endothelium. FACS
analysis indeed confirmed targeting of cKit+ hemogenic endo-
thelium in the yolk sac (Figure S6D). Consistent with immunoflu-
orescence data showing efficient targeting of the dorsal aorta
and vitelline artery, the major intra- and extraembryonic hemo-
genic vessels, FACS analysis at E11 revealed that a major
population of Pdgfb-CreERT2-traced cells in the embryo proper
expressed cKit protein (Figure S6D). Together, these results
suggest that arterial or hemogenic endothelium can generate
mesenteric LEC progenitors.
cKit Lineage Progenitors of Hemogenic Endothelial
Origin Contribute to Mesenteric Lymphatic Vessels
To specifically test the involvement of hemogenic endothelium-
derived progenitors in lymphatic development, we used the
inducible cKit-CreERT2 mice (Klein et al., 2013). Despite the
expression of cKit in hemogenic endothelium (Marcelo et al.,
2013; Figure S7A), the cKit-CreERT2 line did not label efficiently
yolk sac vasculature that contains hemogenic endothelium be-
tween E7.5 and E9.5, and only rare hematopoietic cells could
be traced (Figure S7B). However, 4-OHT administration to preg-
nant females at E10 (data not shown) or E11 (Figures 5A and 5B)
resulted in the presence of traced GFP+ cells in mesenteric
LEC clusters in E13.5 cKit-CreERT2;R26-mTmG embryos.
Only a proportion of embryos (5 of 17, 29%) showed GFP+
LECs, most likely due to a low, although highly specific, recom-
bination in cKit+ cells (Figure 5A). Lineage tracing using Vav-Cre
(de Boer et al., 2003) showed that definitive hematopoieticCellcells did not, however, contribute to mesenteric lymphatic
vessel development (Figure 5C). These data demonstrate the
cKit lineage hemogenic endothelium-derived progenitors, but
not definitive hematopoietic cells, as the source of mesenteric
LECs.
Mesenteric Lymphatic Vessel Formation Selectively
Requires Pdgfrb Lineage Cells
Yolk sac hemogenic endothelium recently was shown to
generate, during a narrow window of time between E8.5 and
E9.5, cells that colonize the embryo mesenchyme and express
mesenchymal markers including PDGFRb (Azzoni et al., 2014).
Interestingly, we found that Pdgfrb-Cre transgene (Foo et al.,
2006) labeled a significant proportion (38.9% ± 4.7%, n = 24)
of Prox1+ cells within mesenteric LEC clusters (Figure 6A).
FACS analysis of LECs from E13.5 Pdgfrb-Cre;R26-mTmGmes-
enteries revealed a similar recombination efficiency, but with
high inter-individual variation (Figure 6B). As expected, Pdgfrb-
Cre-mediated recombination was not, however, restricted to
LECs. Consistent with the reported expression of PDGFRb
(Foo et al., 2006), recombination also was observed in a large
population of mesenchymal and perivascular cells (Figure 6A;
data not shown). In addition, we observed low levels of recombi-
nation in BECs in multiple tissues (data not shown).
To provide evidence for the functional importance of the
Pdgfrb-expressing cells for mesenteric lymphatic vessel devel-
opment, we deleted Vegfr3, the key regulator of lymphangiogen-
esis, in these cells by crossing Pdgfrb-Cre;R26-mTmGmice with
Vegfr3flox animals (Haiko et al., 2008). Analysis of mesenteries
between E15.5 and E18.5 revealed the absence of lymphatic
vessels in 44% of the Vegfr3flox/flox;Pdgfrb-Cre embryos (n =
16) (Figures 6C and 6D). Similar to the Vegfr3lz/+;p110aD933A/+
embryos, mesenteric lymph sac also was reduced in size or ab-
sent in the majority of those Vegfr3flox/flox;Pdgfrb-Cre embryos
that showed lymphatic defects (Figure 6E). However, lymphatic
vessels of the thoracic skin formed in all (12 of 12)
Vegfr3flox/flox;Pdgfrb-Cre embryos analyzed (Figure 6C; data not
shown). These results demonstrate a selective requirement of
Pdgfrb-expressing LECprogenitor cells formesenteric lymphatic
vessel development, and they provide functional evidence for or-
gan-specific mechanisms of vessel formation.
In conclusion, our results demonstrate organ-specific mecha-
nisms of lymphangiogenesis and origin of the vasculature. Con-
trary to current dogma that veins are the sole origin of the entire
lymphatic vasculature in mammals (Srinivasan et al., 2007), we
show that part of themesenteric lymphatic vasculature is derived
from cKit lineage progenitor cells of hemogenic endothelial origin
(Figure 7). Our data further indicate that these progenitors give
rise to LECs in the mesentery through a lymphvasculogenic pro-
cess that is critically dependent on VEGFR-3/PI3K signaling.
DISCUSSION
Human vascular diseases are often restricted to specific vessel
types or vascular beds of specific organs, but what underlies tis-
sue-specific vessel failure is poorly understood. In this study we
uncover an organ-specific role for VEGFR-3/PI3K signaling in
mesenteric lymphatic vessel formation. We further identifyReports 10, 1708–1721, March 17, 2015 ª2015 The Authors 1713
Figure 3. MLVs Form via the Assembly of Isolated LEC Clusters
(A) Whole-mount immunofluorescence of the developing MLVs from three embryos harvested at E13.5 for indicated proteins, showing different stages of LEC
cluster formation and coalescence. Note the presence of isolated LEC clusters (arrowhead) in the absence of sprouts from the MLS. Asterisks, intestinal wall.
(B) Analysis of LEC cell shape with membrane-bound GFP in E13.5 Vegfr3-CreERT2;R26-mTmG vessels. 4-OHT (2 mg) was administered at E11.5 to induce
mosaic LEC labeling. Arrowheads point to non-polarized filopodia.
(legend continued on next page)
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hemogenic endothelium as a previously unknown tissue of origin
for lymphatic vessels in the mesentery. Our results suggest that
heterogeneity in endothelial origin may contribute to tissue-spe-
cific formation and functional specialization of vessels during
development and vessel failure in disease.
VEGFR-3 is the key regulator of lymphangiogenesis, control-
ling lymphatic endothelial cell proliferation, migration, and sur-
vival. Inhibition of VEGFR-3 signaling in the mouse skin using a
soluble ligand trap led to lymphatic vessel hypoplasia, while ge-
netic deletion of its ligand, Vegfc, resulted in a complete absence
of lymphatic vasculature due to failure of vessel sprouting from
the veins (Ha¨gerling et al., 2013; Karkkainen et al., 2004;Ma¨kinen
et al., 2001a). As expected from these results, homozygous dele-
tion of Vegfr3 resulted in severe lymphatic vessel hypoplasia in
multiple tissues, including the skin and mesentery (L.S. and
T.M., unpublished data and this study). The VEGFR-3 down-
stream signaling events controlling the different endothelial cell
responses during vascular morphogenesis remain unclear, but
in vitro studies have shown that VEGFR-3 activates the Ras/
MAPK and PI3K/Akt pathways (Coso et al., 2012; Lapinski
et al., 2012; Ma¨kinen et al., 2001b).
PI3K signaling, particularly through its catalytic subunit p110a,
has emerged as a key regulator of vascular development (Grau-
pera and Potente, 2013). p110a is critically required for endothe-
lial cell migration downstream of VEGFR-2 during angiogenesis
(Graupera et al., 2008), while its aberrant activation has been
implicated in the development of blood and lymphatic vascular
malformations in human syndromes (Brouillard et al., 2014). In
this study we identified a strong genetic interaction between
p110a and Vegfr3 during mesenteric and intestinal, but not
dermal lymphatic development, suggesting a cooperative func-
tion of these genes selectively in the mesentery. In agreement
with this observation, lymphatic endothelial-specific full deletion
of p110a resulted in a selective failure of mesenteric lymphatic
vessel formation. Contrary to its role in controlling BECmigration
upon VEGF/VEGFR-2 activation, p110a deficiency did not impair
lymphatic vessel sprouting in embryonic skin. These data sug-
gest that p110a regulates different functions downstream of
VEGFR-2 and VEGFR-3 in BECs and LECs, respectively. The or-
gan-specific role of p110a further indicates that, in tissues other
than the mesentery, VEGFR-3 signaling does not depend on
p110a. Previous studies have shown the requirement of the
PI3K regulatory subunits p85/p55/p50a and the interaction of
Ras with p110a in the development and remodeling of multiple
lymphatic vascular beds (Gupta et al., 2007; Mouta-Bellum
et al., 2009). It is therefore possible that p110a function is
compensated by the p110b and/or p110d subunits in lymphatic
vascular beds other than the mesentery.(C) Quantification of nuclear morphology of LECs in clusters (n = 135 cells), vessel
represent mean values. ***p < 0.0001.
(D–F) Whole-mount immunofluorescence of isolated LEC clusters and MLS for in
and F) for indicated stainings.
(G) Whole-mount immunofluorescence of E14 Cldn5-GFPmesenteries for indicat
blood vessel and LS endothelia.
(H) Quantification of GFP fluorescence intensity in endothelial cells in E14 Cldn5-
cells are shown. V, vein; A, artery. The horizontal lines represent mean values. **
See also Figure S4.
Scale bars, 100 mm (A), 20 mm (B and G, right), 50 mm (D–F), and 500 mm (G, left
CellThe origin of the lymphatic vasculature has been debated for
over a century. Florence Sabin described in the early 20th century
that lymphatic vessels are derived from embryonic veins (Sabin,
1902). Recent molecular biological data not only support the
concept of transdifferentiation of venous into LECs, but also sug-
gest that they are the sole origin of the entire lymphatic vascula-
ture in mammals (Oliver and Srinivasan, 2010; Srinivasan et al.,
2007). Other contributing sources of LECs have been suggested
though never demonstrated to contribute to mammalian
lymphatic vasculature. In the early 1900s, Huntington and
McClure proposed that LECs derive from mesenchymal precur-
sors (Huntington and McClure, 1910). Based on expression ana-
lyses, such precursor cells were described in Xenopus (Ny et al.,
2005), chicken (Wilting et al., 2000), and mouse (Buttler et al.,
2006), although no functional validation has been provided.
Grafting experiments further suggested that avian lymphatic
vasculature is of dual origin, with a contribution from both
venous- and mesenchymal-derived cells (Wilting et al., 2006).
In addition, hematopoietic cell-derived endothelial progenitors
and transdifferentiating leukocytes and macrophages were
shown to participate in pathological lymphangiogenesis (Ker-
jaschki et al., 2006; Maruyama et al., 2005; Salven et al., 2003).
The identity of these additional sources of LECs and their
requirement for lymphatic vascular morphogenesis, however,
was questioned by findings that demonstrated the venous origin
of LECs (Oliver and Srinivasan, 2010; Srinivasan et al., 2007), and
excluded macrophages as a source of lymphatic endothelia
(Gordon et al., 2010). In this study we identified cKit lineage he-
mogenic endothelial cells as a novel, organ-specific origin of
mesenteric lymphatic vessels. Mesenteric lymph sac instead
forms from venous-derived LECs, with a minor contribution
from the hemogenic endothelium-derived progenitors.
Similar to the two processes of blood vessel formation, vascu-
logenesis, and angiogenesis, the mechanisms of mesenteric
lymph sac and vessel formation are fundamentally different.
Blood vessel formation is initiated in the developing embryo via
differentiation and assembly ofmesodermal precursor cells (vas-
culogenesis), after which most if not all blood vessel formation
occurs via sprouting from pre-existing vasculature (angiogen-
esis). We found that mesenteric lymphatic vascular development
occurs in a fundamentally different manner. It is initiated at E12.5
via formation of themesenteric lymph sac through an angiogenic
process that involves LEC differentiation within and sprouting
from the veins. The mesenteric lymphatic vessels are formed
subsequently via differentiation and assembly of lymphatic
endothelial progenitors of hemogenic endothelial origin into
cell clusters and vessels through a process resembling vasculo-
genesis, which we thus defined as lymphvasculogenesis. Durings (n = 141 cells), and developing LS (n = 123 cells) at E13.5. The horizontal lines
dicated proteins. Single-channel images are shown for the boxed regions in (E
ed proteins. Note GFP LEC cluster (arrowhead) but strong GFP expression in
GFP mesenteries. For LECs, single cells and clusters of two and three to four
*p < 0.0001.
).
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Figure 4. MLVs Originate from Non-venous Endothelium
(A) Schematic of the Cre transgene, R26-mTmG reporter construct, and 4-OHT administration protocol (red arrowhead, 2 mg) used for lineage tracing.
(B) Tile scans of E14Pdgfb-CreERT2;R26-mTmGmesenteries stainedwith antibodies against GFP (green) andNrp2 (red). Single-channel images are shown. Note
weak GFP staining (asterisk) in the artery from the ires-GFP cassette within the Pdgfb-CreERT2 transgene.
(C) Immunofluorescence staining of E9.5 Pdgfb-CreERT2;R26-mTmGwhole embryo (top) and transverse vibratome section (bottom) for indicated proteins. Note
efficient Cre-mediated recombination (green) in dorsal aorta (DA), vitelline (VA), and umbilical artery (UA), and yolk sac (YS) vasculature, but not in cardinal vein
(CV). Boxed area is magnified in the middle.
(legend continued on next page)
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Figure 5. MLVs Derive from cKit Lineage
Cells of Hemogenic Endothelial Origin
(A) (Top) Schematic of the Cre transgene, R26-
mTmG reporter construct, and 4-OHT administra-
tion protocol (red arrowhead, 2mg) used for lineage
tracing. (Bottom) FACS analysis of endothelial cells
from E13.5 cKit-CreERT2;R26-mTmG embryos
showing specific but inefficient Cre-mediated
recombination in cKit+ cells. Representative FACS
plots and gating scheme and graph of all results are
shown. The horizontal lines represent mean (n = 4).
(B) Tile scans of E13.5 cKit-CreERT2;R26-mTmG
mesenteries stained with antibodies against GFP
(green) and Nrp2 (red).
(C) Schematic of the Vav-Cre transgene and R26-
mTmG reporter construct, and whole-mount immu-
nofluorescence of mesenteric vessels from E14.5
Vav-Cre;R26-mTmG embryo for GFP (green) and
Nrp2 (red). Single-channel image for GFP is shown.
See also Figure S7.
Scale bars, 50 mm.this process, mesenteric LECs extend long filopodia that inter-
connect cells from different clusters. These often non-polarized
filopodia may play a role in cell-cell communication during clus-
ter coalescence, similar to the role of blood endothelial filopodia
in vessel anastamosis (Lenard et al., 2013; Phng et al., 2013).
Hemogenic endothelium is a de novo source of transient defin-
itive hematopoietic progenitors during a narrow developmental
window between E7.5 and E11 of mouse development, before
first liver and then bone marrow become the main hematopoietic
organs. Hemogenic endothelium is found at specific anatomical
sites, including the yolk sac, placenta, vitelline artery, and the
AGM region that contains the dorsal aorta (Hirschi, 2012).
Recently, a subset of endocardial cells in the outflow cushion
and atria of the heart also was shown to possess hemogenic ac-
tivity, suggesting the existence of organ-specific sites of embry-
onic hematopoiesis (Nakano et al., 2013). Interestingly, the prog-
eny of hemogenic endothelial cells may be functionally different
depending on their site of origin (Hirschi, 2012). It therefore will
be important to define the specific anatomic site(s) that gives(D) FACS analysis of endothelial cells from E10.25 and E11 Pdgfb-CreERT2;R26-mTmG embryos showing low
derived LECs. Representative FACS plots and gating scheme (shown for E10.25) and graph of all results ar
[E10.25] or n = 3 [E11]).
See also Figures S5 and S6.
Scale bars, 100 mm.
Cell Reports 10, 1708–1721rise to mesenteric LEC progenitors. How-
ever, due to a limitation of tools for tracing
cells of hemogenic endothelial origin at
different developmental stages, it was
not possible to define the timing and
contribution of different hemogenic sites
to the generation of mesenteric LECs in
this study. 4-OHT induction of cKit-
CreERT2 at E10 or E11 did not allow us to
distinguish if the source of mesenteric
LECs are cKit+ progenitors, derived eitherfrom extra- or intraembryonic hemogenic endothelium, or cKit+
hemogenic endothelium in the embryo proper (including AGM),
which are all present at E10–E11. Unveiling how the hemogenic
endothelial-derived progenitors reach the mesenteries is also an
interesting question for further research. One possibility is that
they arrive via circulation, which is followed by their extravasa-
tion and differentiation into LECs. Alternatively, these cells may
migrate directly from the site of emergence to the mesentery.
In support of the latter possibility, it has been shown that primi-
tive myeloid progenitors that arise in the yolk sac before E8
migrate to the cephalic region of the embryo before the onset
of blood circulation and develop into microglia (Alliot et al.,
1999; Ginhoux et al., 2010).
It has been suggested that differences in embryonic origins of
vascular smooth muscle cells can contribute to tissue-specific
localization of vascular diseases, such as aortic aneurysm and
vascular calcification (Sinha et al., 2014). It is similarly plausible
that organ-specific manifestation of lymphatic vessel dysfunc-
tion in disease is due to vascular bed-specific differences in theirCre-mediated recombination efficiency in venous-
e shown. The horizontal lines represent mean (n = 5
, March 17, 2015 ª2015 The Authors 1717
Figure 6. Vegfr3 Deletion Using the Pdgfrb-Cre Leads to Organ-Specific Defect in MLV Formation
(A) (Left) Schematic of the Pdgfrb-Cre transgene and R26-mTmG reporter construct. (Middle) Whole-mount immunofluorescence of mesenteric LEC clusters in
Pdgfrb-Cre;R26-mTmG mesentery. (Right) Quantification of GFP+ LECs within mesenteric clusters. The horizontal line represents mean (n = 24).
(B) FACS analysis of LECs from E13.5 Pdgfrb-Cre;R26-mTmG embryos showing variable Cre-mediated recombination. Representative FACS plot and graph of
all results are shown. The horizontal line represents mean (n = 5).
(C) Whole-mount immunofluorescence of E15.5 control and Vegfr3flox/flox;Pdgfrb-Cremesenteries and upper thoracic skin for indicated proteins, showing organ-
specific defect in MLV formation in the mutant. LV, lymphatic vessel (Nrp2+); V, vein (Endomucin+); N, nerve (Nrp2+).
(D and E) Quantification of MLV and MLS phenotypes in Vegfr3flox/flox;Pdgfrb-Cre embryos. Complete in (E) represents the size of LS in control littermates (n = 6).
Scale bars, 50 mm (A) and 200 mm (C).origin and formation. It is interesting to note that several primary
lymphedemas affect vessels of specific tissues. For example, in
Milroy disease, caused by kinase-inactivating mutations in the
VEGFR-3 gene, lymphedema is restricted to the lower limbs
while lymphatic function in the forearms is unimpaired (Mellor
et al., 2010).
In summary, we show that part of the mesenteric lymphatic
vasculature forms from cKit lineage progenitor cells of hemo-
genic endothelial origin, and not solely from the venous-derived
lymph sac as previously thought. We additionally show that mo-
lecular mechanisms regulating the development of lymphatic
vessels from venous- and non-venous-derived progenitors are
different. These findings reveal a hitherto unrecognized organ-
specific mechanism of lymphatic vascular morphogenesis,
and they raise the possibility that heterogeneity in the cell of1718 Cell Reports 10, 1708–1721, March 17, 2015 ª2015 The Authororigin contributes to tissue-specific vascular properties and dis-
ease. In addition, our study identifies a progenitor cell popula-
tion with potential for therapeutic exploitation to induce
lymphatic regeneration following cancer surgery, lymphedema,
or tissue trauma. Given the emerging roles of lymphatic vessels
in inflammation, immunity, and lipid metabolism, lymphatic
endothelial progenitors additionally may provide a novel strat-
egy to treat common diseases associated with lymphatic
dysfunction.EXPERIMENTAL PROCEDURES
Mice
Description of mouse strains is provided in the Supplemental Experimental
Procedures. Staging of E9 and E10 embryos was done by counting somites
Figure 7. Two Origins of the Mesenteric Lymphatic Vasculature
Schematic model of mesenteric lymphatic vascular development. Venous-
derived LECs form the retroperitoneal (M)LS at the root of the mesentery.
MLVs instead form by differentiation of cKit lineage progenitors of hemogenic
endothelial origin. Blue, venous EC; light red, arterial EC; green, LEC; and dark
red, non-venous LEC progenitors.pairs. Embryos harvested before 10 a.m. were typically of stages E0.0–E0.25.
For staging of embryos older than E11, the morning of vaginal plug detection
was thus considered as E0. For induction of Cre recombination, 4-OHT dis-
solved in peanut oil (10 mg/ml) was administered to pregnant females by intra-
peritoneal injections as indicated in figures and/or legends. All mice were
maintained on a C57BL/6J genetic background. Experimental procedures
were approved by the United Kingdom Home Office and the Uppsala Labora-
tory Animal Ethical Committee.
Immunofluorescence
For whole-mount immunofluorescence, tissues were fixed in 4% paraformal-
dehyde (PFA) for 2 hr at room temperature. The samples were washed in
PBS, permeabilized in 0.3%-Triton X-100 in PBS (PBSTx) or 1% Triton for
E9.5 embryos, and blocked in PBSTx with 3%milk. This was followed by incu-
bation with primary antibodies at 4C overnight in blocking buffer, washing in
PBSTx, and incubation with fluorochrome-conjugated secondary antibodies
in blocking buffer for 2 hr at room temperature. The tissues were washed
and mounted in Mowiol. For E9.5 whole-mount staining, primary and second-
ary antibodies were incubated for 24 hr each, followed by 8 hr washing in
PBST. Details of antibodies are provided in the Supplemental Experimental
Procedures.
Flow Cytometry
Embryonic back skin, mesenteries, whole embryos, and yolk sacs were har-
vested and the tissues were cut into smaller pieces for digestion using a
mixture of 1–5 mg/ml Collagenase IV (Life Technologies) and 0.2 mg/ml
DNase (Roche) in PBS with 2%–10% fetal bovine serum (FBS) at 37C under
constant rotation for 8–20 min, depending on the tissue. Digests were
quenched by adding 2 mM EDTA and filtered through a 70-mm nylon filter
(BD Biosciences). Cells were washed with FACS buffer (PBS, 0.5% FBS,
and 2 mM EDTA) and immediately processed for staining in 96-well
plates. Fc receptor binding was blocked by rat-anti-mouse CD16/CD32
(eBioscience) in all experiments. Details of antibodies are provided in the Sup-
plemental Experimental Procedures. For compensation, the AbC anti-rat/
hamster compensation bead kit (Life Technologies) was used. The cells
were analyzed on a FACSaria cell sorter utilizing the FACSDiva software
(BD Biosciences). Data were processed using FlowJo software (Tree Star).
Single cells were gated using FSC-H/FSC-W and SSC-H/SSC-W. FMO con-
trols were used to set up the subsequent gating schemes. All data are pre-
sented using biexponential display.CellImage Acquisition and Quantification
All confocal images except Figure 5A represent maximum intensity projections
of z stacks of single-tile or multiple-tile scan images (see Table S1 for details).
Images were acquired using Zeiss 700, 710, or 780 confocal microscopes and
Zen 2009-2011 software. Stereomicroscopic images of tissues were acquired
with a Leica MZ16F fluorescence microscope equipped with Leica DFC420C
camera and Leica Microsystems software. Details about quantification are
provided in the Supplemental Experimental Procedures.
Statistical Analysis
GraphPad Prism version 6.0f software was used for graphic representation
and statistical analysis of the data. Unpaired t test was applied and results
considered statistically significant when p < 0.05. Comparisons among multi-
ple groups in Figures 3C and 3G were done by one-way ANOVA (Tukey’s mul-
tiple comparison test).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.02.026.
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